Recent claims on social media suggesting that contraceptive pills have been newly labelled as a ‘Group 1 cancer-causing agent’ have led to widespread debate and confusion. The International Agency for Research on Cancer (IARC) did categorize combined estrogen-progestogen oral contraceptives in Group 1, indicating sufficient scientific evidence of potential cancer-causing properties under certain scenarios. However, health experts stress that this classification isn’t new and doesn’t imply that taking the pill will inevitably lead to cancer. The classification merely signifies a found link between specific contraceptives and certain types of cancer. Research indicates that women using these contraceptives may face a marginally increased risk of breast and cervical cancer, which normalizes after discontinuing the pill. Conversely, contraceptive pills may decrease the risk of ovarian and endometrial cancers. Experts stress that Group 1 classification doesn’t quantify danger levels, but only potential cancer-causing ability. They advise seeking professional medical advice rather than solely relying on social media. Birth control continues to be a critical component of reproductive health, and contraceptive decisions should be made with the guidance of a qualified healthcare provider, considering both potential risks and benefits.
Follow us on Instagram: @news.tringlobe
